Business Context and Reporting Period
This Form 8-K Current Report was filed by Quanterix Corporation on August 3, 2023, with the earliest event reported on that date. The filing addresses Item 5.02 regarding the departure of a senior officer and the appointment of a new Chief Financial Officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation terms.
- New CFO Base Salary: $440,000 annualized.
- Annual Performance Bonus Target: 70% of base salary.
- Sign-On Equity Award: $800,000 total value (70% stock options, 30% restricted stock units).
- Target Annual Equity Grant: Up to $1,500,000 in grant date fair value (expected to commence in 2024).
Material Changes
The primary material change is the leadership transition in the finance department effective August 21, 2023:
- Departure: Michael Doyle will cease serving as Chief Financial Officer and Treasurer. He will remain employed as Executive Director, Finance until his retirement on March 31, 2024.
- Appointment: Vandana Sriram has been appointed as Chief Financial Officer. She joins from Azenta, Inc., where she served as Senior Vice President - Global Finance and Principal Accounting Officer.
Outlook, Risks, and Contingencies
The filing details severance and equity acceleration contingencies tied to Ms. Sriram's employment agreement:
- Termination without Cause/Good Reason: Entitles the executive to six months of base salary, prorated target bonus, health benefits continuation, and acceleration of the unvested portion of the first equity tranche.
- Change-in-Control: If termination occurs in connection with a change-in-control, all outstanding unvested equity awards become fully vested.
- Conditions: Receipt of termination benefits requires the execution of a separation agreement including restrictive covenants and a general release of claims.
Investor Verification Checklist
- Verify the effective date of the CFO transition (August 21, 2023) and the interim role of the departing CFO.
- Review the attached Employment Agreement (Exhibit 10.1) for full terms regarding vesting schedules and restrictive covenants.
- Confirm the composition of the $800,000 sign-on equity award (options vs. RSUs) and its impact on dilution.
- Monitor future filings for the 2024 long-term equity award cycle to confirm the $1,500,000 target grant value.